Investors
Overview
Team
Press Releases
SEC Filings
180 Life Sciences
Email Alerts
Contact
SEC Filings
Filing Type:
View All
10-K
10-Q
10-Q/A
25-NSE
3
4
424B3
424B4
425
8-K
8-K/A
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
PRE 14A
S-1
S-4
S-4/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
Date
Form
Description
PDF
XBRL
Pages
02/14/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/13/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/12/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
02/10/20
S-4/A
Registration of securities issued in business combination transactions
Documents
EX-8.2
EX-23.1
EX-23.2
EX-99.1
549
02/07/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
11
02/03/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
EX-2.1
7
02/03/20
8-K
Current report filing
Documents
EX-2.1
7
01/17/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
12/12/19
8-K
Current report filing
Documents
EX-99.1
45
12/12/19
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
EX-99.1
45
Previous
1…
4
5
6
7
8
9
10
11
12
13
Next
Email Alerts
RSS News Feed